Tag: Venture capitalists

Discover how software development is being revolutionized with OpenAI's ChatGPT. With the technology taking programming tasks that used to take 8-10 weeks to a single week, businesses like Freshworks and Octopus Energy have benefited from AI powered tools, while individual workers have seen increased productivity. But with over 300 million jobs being threatened by automation, are AI tools beneficial or detrimental?

Shopify, an industry leader in e-commerce solutions, announces difficult layoffs and logistics arm sale to Flexport. Pando, a fulfillment tech startup, raises $30M ($45M total) signaling robust investment in supply chain sector. Tellus, an Andreessen Horowitz-backed fintech, faces US government scrutiny. Index Ventures' Heymann shares his insights on venture capital and metrics. TechCrunch+ offers founders a discounted membership with access to their AI tech news.

Venture capitalists are recognizing the potential of AI, with 60% of respondents in the PitchBook survey expecting the technology to be major drivers of growth in the next 5 years. Microsoft-backed OpenAI's success, ChatGPT, has sparked an investment trend in the technology. However, the challenges of navigating long-term aims VS short-term gains and the commodification of services and products presents risks that investors must be mindful of.

This Google I/O could be critical for the tech giant as they showcase their AI-driven technologies and attempt to prove their worth in the enterprise market. Microsoft and Google have invested heavily in generative AI, competing for the top spot in the industry. With tech giants like Meta, Snap, and Amazon investing in the field, this is the moment for Google to take the win!

G20 countries urged to collaborate on evidence-based data on healthcare services by Indian official. Ahead of the India-US BioPharma and Healthcare Summit, an Indian G20 Sherpa invites countries to join forces on R&D, clinical trials and global supply chain of medicines and vaccines. Representatives of big BioPharma companies, Harvard, MIT and more to attend.